HCWB HCW BIOLOGICS INC Capital Structure Changes 8-K Filing 2025 - Equity Offerings On May 15, 2025, HCW Biologics Inc. announced that it issued 177,140 shares of common stock after Armistice Capital exercised some pre-funded warrants, and it converted $270,000 in convertible notes into shares at $7.45 each. The conversion provided shares to key executives and included a bonus related to Wugen shares.Get access to all SEC 8-K filings of the HCW BIOLOGICS INC